These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 36438800)
1. M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy. Zhao K; Wei B; Zhang Y; Shi W; Zhang G; Wang Z Front Pharmacol; 2022; 13():1052177. PubMed ID: 36438800 [No Abstract] [Full Text] [Related]
2. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Huang X; Qiu Z; Li L; Chen B; Huang P Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607 [TBL] [Abstract][Full Text] [Related]
3. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer. Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164 [TBL] [Abstract][Full Text] [Related]
4. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma. Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578 [TBL] [Abstract][Full Text] [Related]
5. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment. Zhang W; Xiao P; Tang J; Wang R; Wang X; Wang F; Ruan J; Yu S; Tang J; Huang R; Zhao X Front Immunol; 2022; 13():888650. PubMed ID: 35572541 [TBL] [Abstract][Full Text] [Related]
6. m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma. Li J; Wang W; Zhou Y; Liu L; Zhang G; Guan K; Cui X; Liu X; Huang M; Cui G; Sun R Front Cell Dev Biol; 2021; 9():687756. PubMed ID: 34277630 [No Abstract] [Full Text] [Related]
7. m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment. Liu F; Yu X; He G J Oncol; 2021; 2021():9987376. PubMed ID: 34745261 [TBL] [Abstract][Full Text] [Related]
9. Molecular Characteristics of m6A Regulators and Tumor Microenvironment Infiltration in Soft Tissue Sarcoma: A Gene-Based Study. Xiao KW; Yang ZQ; Yan X; Liu ZB; Yang M; Guo LY; Cai L Front Bioeng Biotechnol; 2022; 10():846812. PubMed ID: 35519620 [No Abstract] [Full Text] [Related]
11. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma. Cai J; Zhou M; Xu J World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer. Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726 [No Abstract] [Full Text] [Related]
13. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer. Yang Q; Xu F; Jian A; Yu H; Ye T; Hu W Front Cell Dev Biol; 2021; 9():803141. PubMed ID: 35198565 [No Abstract] [Full Text] [Related]
14. m6A regulator-mediated methylation modification highlights immune infiltration patterns for predicting risk in hepatocellular carcinoma. Zhou D; Wang Y; Wei W; Zhou W; Gu J; Kong Y; Yang Q; Wu Y J Cancer Res Clin Oncol; 2023 Jul; 149(7):3661-3680. PubMed ID: 35972694 [TBL] [Abstract][Full Text] [Related]
15. Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer. Luo Y; Sun X; Xiong J Front Cell Dev Biol; 2021; 9():794801. PubMed ID: 35087835 [No Abstract] [Full Text] [Related]
16. N Li C; Zhu M; Gao C; Lu F; Chen H; Liu J; Zhong W Front Biosci (Landmark Ed); 2024 Jan; 29(1):33. PubMed ID: 38287827 [TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment. Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma. Yin T; Zhao L; Yao S BMC Med Genomics; 2022 Mar; 15(1):53. PubMed ID: 35260168 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma. Ji J; Liu S; Liang Y; Zheng G BMC Genom Data; 2023 Aug; 24(1):44. PubMed ID: 37568073 [TBL] [Abstract][Full Text] [Related]
20. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J Front Genet; 2021; 12():752025. PubMed ID: 35046996 [No Abstract] [Full Text] [Related] [Next] [New Search]